Medical Condition News

RSS

GTRI develops novel iPhone application for patients with Parkinson's

Researchers at the Georgia Tech Research Institute (GTRI) have developed a novel iPhone application that may enable persons with Parkinson's disease and certain other neurological conditions to use the ubiquitous devices to collect data on hand and arm tremors and relay the results to medical personnel.

24 Jun 2011

Anonymous donor makes generous gift for mesothelioma research

The UH Cancer Center has received a $3.58 million gift from an anonymous donor to support the mesothelioma research of Dr. Michele Carbone, director of the UH Cancer Center. Carbone and colleagues, who include Drs. Haining Yang and Giovanni Gaudino, have made a series of recent scientific breakthroughs that will lead to new ways to prevent and treat the disease

24 Jun 2011

High salt consumption does not seem to increase risk of heart disease

A new eight year long European study concludes that salt consumption is not dangerous and may in fact be beneficial. This is certainly contrary to advice from American Medical Association, American Heart Association and the Center for Disease Control and Prevention, which says higher sodium consumption can increase the risk of heart disease.

24 Jun 2011

Hypertension variability during cardiac surgery may increase risk of death

For patients with hypertension undergoing heart surgery, large variations in blood pressure before, during, and after the operation are associated with an increased risk of death, reports the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Jun 2011

Scientists analyse factors that influence development of burnout syndrome

Being over-burdened with work, monotony and the perception of lack of recognition can all be catalysts for burnout syndrome. A team of scientists has analysed the factors that influence the development of the three sub-types of this condition - 'frenetic', 'under-challenged' and 'worn out'.

24 Jun 2011

Research offers avenue for creating Alzheimer's and HIV therapeutics

A new advance by UCLA biochemists has brought scientists one step closer to developing treatments that could delay the onset of Alzheimer's disease and prevent the sexual transmission of HIV.

24 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

Patients with familial adenomatous polyposis have higher vascular density in mouth

A team led by Johns Hopkins researchers has found that a hereditary colon cancer syndrome, familial adenomatous polyposis (FAP), is associated with abnormally dense blood vessel growth in the skin lining the mouth.

24 Jun 2011

Northwest Hospital wins Silver Plus Performance Achievement Award for stroke care

Northwest Hospital in Randallstown, Maryland, has earned a Silver Plus Performance Achievement Award from The American Heart Association and the American Stroke Association.

24 Jun 2011

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.

24 Jun 2011

Ketogenic diet reduces seizures in mice through adenosine A1 receptors

Some individuals with epilepsy fail to respond to treatment with conventional drugs but benefit from consuming a ketogenic diet - a high-fat, low-carbohydrate diet similar to the more commonly known Atkins diet.

24 Jun 2011

Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease

Mylan Inc. today announced that the U.S. District Court for the District of Delaware has found after trial that Mylan subsidiary Mylan Pharmaceuticals Inc. does not infringe the asserted claims of U.S. Patent No. 5,643,602 with its Abbreviated New Drug Application for Budesonide Capsules, 3 mg, the generic version of AstraZeneca's Entocort EC capsules, a treatment for Crohn's disease.

24 Jun 2011

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

24 Jun 2011

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has received an opinion on its Marketing Authorisation Application (MAA) for Glybera as a potential therapy for Lipoprotein Lipase Deficiency.

24 Jun 2011

Hunger hormone likely to cause stress-linked complex eating behaviors

We are one step closer to deciphering why some stressed people indulge in chocolate, mashed potatoes, ice cream and other high-calorie, high-fat comfort foods. UT Southwestern Medical Center-led findings, in a mouse study, suggest that ghrelin - the so-called "hunger hormone" - is involved in triggering this reaction to high stress situations.

24 Jun 2011

Millennium reports ongoing MLN8237 Phase II study results on non-Hodgkin lymphoma

Millennium: The Takeda Oncology Company today announced the presentation of results from an ongoing Phase II study of MLN8237, an investigational Aurora A kinase inhibitor, in patients with relapsed/refractory aggressive B-cell and T-cell non-Hodgkin lymphoma.

24 Jun 2011

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Idera Pharmaceuticals, Inc. announced today the presentation of IMO-3100 mechanism of action data in a preclinical model of arthritis.

24 Jun 2011

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

A side effect of many commonly used drugs appears to increase the risks of both cognitive impairment and death in older people, according to new research led by the University of East Anglia.

24 Jun 2011

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical trial of patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease.

24 Jun 2011

Potential new approach for treating myelofibrosis

A new study conducted by a team of researchers at Boston University School of Medicine (BUSM) sheds light on a possible new approach to treat the bone marrow disease known as myelofibrosis by inhibiting an enzyme that connects extracellular fibers.

24 Jun 2011

Medical Condition News

GTRI develops novel iPhone application for patients with Parkinson's

Anonymous donor makes generous gift for mesothelioma research

High salt consumption does not seem to increase risk of heart disease

Hypertension variability during cardiac surgery may increase risk of death

Scientists analyse factors that influence development of burnout syndrome

Research offers avenue for creating Alzheimer's and HIV therapeutics

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Patients with familial adenomatous polyposis have higher vascular density in mouth

Northwest Hospital wins Silver Plus Performance Achievement Award for stroke care

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Ketogenic diet reduces seizures in mice through adenosine A1 receptors

Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

Hunger hormone likely to cause stress-linked complex eating behaviors

Millennium reports ongoing MLN8237 Phase II study results on non-Hodgkin lymphoma

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

Potential new approach for treating myelofibrosis

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News